Abstract. House finches are competent hosts for both West Nile and St. Louis encephalitis viruses and frequently become infected during outbreaks. In the current study, House finches were infected initially with either West Nile or St. Louis encephalitis viruses and then challenged 6 weeks post infection with either homologous or heterologous viruses. Although mortality rates were high during initial infection with West Nile virus, prior infection with either virus prevented mortality upon challenge with West Nile virus. Prior infection with West Nile virus provided sterilizing immunity against both viruses, whereas prior infection with St. Louis encephalitis virus prevented viremia from St. Louis encephalitis virus, but only reduced West Nile virus viremia titers. Immunologic responses were measured by enzyme immunoassay and plaque reduction neutralization tests. Heterologous challenge with West Nile virus in birds previously infected with St. Louis encephalitis virus produced the greatest immunologic response, markedly boosting antibody levels against St. Louis encephalitis virus. Our data have broad implications for free-ranging avian serological diagnostics and possibly for the recent disappearance of St. Louis encephalitis virus from California.
St. Louis encephalitis (SLEV) and West Nile (WNV) viruses are members of the Japanese encephalitis serogroup within the genus Flavivirus whose distributions did not overlap prior to the invasion of North America by WNV. [1] [2] [3] The introduction of WNV into New York in 1999 was followed rapidly by the dispersal of WNV across North America into areas historically endemic for SLEV, including California, Florida, and Texas. 4, 5 During the summer of 2003, WNV invaded the southeastern deserts of California, 6 an area supporting SLEV transmission, 7 thereby allowing us to test the notion that 2 antigenically similar arboviruses may not occupy the same niche at the same time. In southern California, both viruses are transmitted primarily by Culex tarsalis Coquillett in rural landscapes and by Cx. pipiens quinquefasciatus Say in urban settings 6, 8, 9 and presumably are maintained by infections in House finches (Carpodacus mexicanus) and House sparrows (Passer domesticus). 2, 10, 11 Acquisition of protective immunity following infection in the primary avian maintenance hosts could be one of several factors affecting the co-existence of antigenically similar arboviruses. Acquired immunity persists into the following season, because House finches challenged with the same SLEV strain retained protective immunity into the summer after the year of infection, even though neutralizing antibody titers decayed rapidly, 12 agreeing with previous results for House sparrows. 13 The extent of cross protection from acquired immunity to SLEV against WNV has not been studied in Passeriform birds. Using a hamster model to study WNV infection outcome, 14 previous infection or immunization with SLEV and other members of the Japanese encephalitis serogroup protected hamsters against fatal WNV disease but did not prevent viremia during acute infection. 15 The reciprocal experiment was not done, although presumably previous WNV infection also would provide cross protection against challenge with SLEV.
The objective of the current experiment was to describe the degree of homologous and heterologous protection afforded by prior WNV or SLEV infection in House finches. We selected House finches for this research because they are abundant throughout California (http://www.mbr-pwrc.usgs.gov/ bbs/bbs.html), easy to maintain in captivity, frequently fed upon by Cx. tarsalis, 16 a mosquito with which they exchange a number of arboviruses and malaria parasites, [17] [18] [19] and are competent hosts for SLEV and WNV. 8, [20] [21] [22] The complexity of avian Flavivirus serology was explored using field samples from 2 study areas in California with active WNV transmission, but with differing recent histories of SLEV transmission.
MATERIALS AND METHODS
Virus strains. We used the NY strain of WNV isolated from a Flamingo that died in the Bronx Zoo (strain 35211 AAF 9/23/99) and that previously was passaged twice in Vero cells. The Kern217 strain of SLEV isolated from Cx. tarsalis collected in Bakersfield in 1989 also had been passaged twice in Vero cells prior to use. Both virus strains have been used extensively in host competence studies in our laboratory. 8, 21 Avian infection. House finches were collected from Vineyards near Bakersfield during the summer of 2003, before the introduction of WNV into Kern County, California. 23 Birds were banded, bled to determine antibody status, and maintained for 1-2 weeks to observe general health and adaptation to confinement. Sera taken prior to infection were tested for antibodies against western equine encephalomyelitis virus (Togaviridae, Alphavirus, WEEV) and SLEV using an enzyme immunoassay (EIA). 24 Birds were fed mixed bird seed and housed in mosquito-proofed and air-conditioned infection units.
Birds were inoculated subcutaneously with 3-4 log 10 PFU of each virus in the cervical region. Previous studies have shown that comparable titers of SLEV delivered by syringe or infectious mosquito bite produced similar viremia and anti-body responses in House finches. 25 Birds were bled by jugular venipuncture (0.1 mL blood taken by 28 g syringe and expelled into 0.4 mL virus diluent) daily for 6-7 days post inoculation (dpi) to monitor viremia and then weekly for 4-6 weeks to monitor antibody (0.1 mL blood into 0.9 mL saline). Virus diluent contained buffered saline, 20% fetal bovine sera and antibiotics. Initially, 16 birds were inoculated with each virus and 16 birds were inoculated with virus diluent and bled concurrently as negative controls. Because of elevated mortality among birds infected with WNV, 20 additional birds were infected with WNV and 6 of these that survived acute infection were added to the previously WNV-infected group to measure the effects of heterologous challenge with SLEV. During challenge, 4 previous control birds each were infected for the first time with WNV or SLEV as positive controls, whereas 8 birds were inoculated with diluent to measure any possible nonspecific reactivity to fetal bovine sera included in our virus diluent and to monitor mortality related to handling, blood sampling, and maintenance.
Assays. Viremia titers were measured by standard plaque assay on Vero cell culture. 26 Antibody response was measured by an indirect EIA and by a plaque reduction neutralization assay (PRNT) using virus grown on Vero cell culture. 24 To be considered positive, EIA antigen positive over antigen negative well optical density (P/N) ratios had to be > 2.0 and sera had to neutralize > 80% of virus at a dilution of 1:20. For statistical analyses, we used the log e transformed reciprocal of the PRNT 80 end point titers for each virus; means presented graphically were the back transformed reciprocal of geometric mean titers.
Field data. To illustrate that cross reactivity may be a problem when testing sera from field-collected free-ranging birds, we compared results from our field sampling program in Los Angeles County without a history of recent SLEV activity to Coachella Valley, Riverside County, with a recent history of SLEV activity. [27] [28] [29] Birds were collected as part of our longterm studies on free-ranging avian seroprevalence at these same areas. 30 Recent surveillance reporting the testing of mosquitoes and sentinel chickens in California were summarized from weekly Arbovirus Surveillance Bulletins.
RESULTS
All birds used in these experiments were negative for antibody against WEEV and SLEV when tested prior to infection. All control birds survived our maintenance and bleeding protocols and remained negative for WNV and SLEV and antibodies when tested by plaque assay, EIA, and PRNT during initial and challenge infections.
Mortality post infection was detected only in birds infected for the first time with WNV ( Table 1) . Ten of 16 birds died during the initial WNV infection and 3 of 4 positive controls died during challenge on 6-7 dpi. In addition, 12 of 20 birds (60%) in the second WNV infection died on 6-8 dpi (data not shown). None of the birds infected with SLEV or inoculated with diluent died. Control birds were housed in separate cages within the same building and bled concurrently with WNV-inoculated birds. Prior infection with either WNV or SLEV prevented mortality in all birds after homologous or heterologous challenge.
Viremia profiles for birds initially infected and challenged were measured daily up to 7 dpi ( Figure 1 ). Mean viremia for birds infected with WNV peaked on 3 dpi at 7.3 and 8.0 log 10 PFU/mL during the initial infection and in the positive control group monitored during challenge, respectively. In marked contrast, birds initially infected with SLEV produced viremias that peaked on 3 and 2 dpi at 3.0 and 2.8 log 10 PFU/mL for initial infection and positive control groups, respectively. Birds surviving previous infection with WNV produced sterilizing immunity against both WNV and SLEV at challenge 6 weeks post infection (i.e., virus was not detected in birds within WNV:WNV or WNV:SLEV groups). In contrast, although initial infection with SLEV produced protective immunity upon homologous challenge with SLEV, birds challenged with WNV exhibited a viremia that peaked on 3 dpi at a mean of 4.6 (range, 2.7-6.4) log 10 PFU/mL. The immune response to initial and challenge infections was monitored for both SLEV and WNV using EIA and PRNT (Figures 2 and 3 ). Antibody at 6 weeks after initial infection in challenged birds and before initial infection for positive and negative controls was compared with antibody FIGURE 1. Mean (+Std Dev) viremia (log 10 plaque forming units (PFU)/mL of blood) for House finches plotted as a function of time in days after inoculation during the initial (V1-V7) and challenge (C1-C6) viremia periods. Minimal threshold for virus detection shown by horizontal arrow was 1.7 log 10 PFU/mL. levels during 6 weeks after infection using a repeated measures ANOVA 31 with virus treatment as the main effect. All serological test results except for the negative controls showed a significant increase over time. When sera were tested by EIA using SLEV antigen, mean positive over negative well ratios varied significantly among virus treatments (F ‫ס‬ 11.6, df ‫ס‬ 6, 29, P < 0.001), bleed dates (F ‫ס‬ 7.4, df ‫ס‬ 6, 36; P < 0.001), and virus by date interaction (F ‫ס‬ 3.3, df ‫ס‬ 36,167; P < 0.001). As shown in Figure 2A , ratios increased most rapidly for the SLEV:SLEV group, followed by the WNV:SLEV group. Lowest ratios were observed for initial infections with WNV. A similar pattern was seen for neutralizing antibody detected by PRNT using SLEV; i.e., virus treatment (F ‫ס‬ 21.9; df ‫ס‬ 6, 29; P < 0.001), weeks post challenge (F ‫ס‬ 7.1; df ‫ס‬ 6, 36; P < 0.001), and interaction (F ‫ס‬ 5.4; df ‫ס‬ 36, 156; P < 0.001) terms were all highly significant in the ANOVA. Examination of Figure 3A revealed that most variation was caused by the pronounced antibody response by the SLEV:WNV group, which had a backtransformed geometric mean titer peaking on week 2 post challenge at 1:3,600. Interestingly, the heterologous challenge created a response that was greater than the homologous challenge response that peaked at 1:250 on week 4.
The mean response to WNV antigen or virus was somewhat different. When sera were tested by EIA using WNV antigen, mean positive over negative well ratios varied significantly among virus treatments (F ‫ס‬ 43.1, df ‫ס‬ 5, 22, P < 0.001), bleed dates (F ‫ס‬ 10.1, df ‫ס‬ 6, 30; P < 0.001), and virus by date interaction (F ‫ס‬ 2.2, df ‫ס‬ 30,116; P < 0.001). Highest values were observed for the WNV:SLEV heterologous challenge group, followed by the WNV:WNV homologous challenge group (Fig. 2B) . In general, P/N ratio values for WNV antigen were lower than observed for SLEV antigen ( Fig.  2A) , and the SLEV-positive control group remained negative throughout; i.e., P/N < 2.0. Even the SLEV:SLEV group failed to elicit a cross reactive response > 3.0. All 3 factors in the ANOVA were again highly significant when sera was tested by PRNT using WNV; i.e., virus treatment (F ‫ס‬ 65.1; df ‫ס‬ 6, 29; P < 0.001), weeks post challenge (F ‫ס‬ 30.9; df ‫ס‬ 6, 36; P < 0.001), and interaction (F ‫ס‬ 6.3; df ‫ס‬ 36, 161; P < 0.001) were all highly significant. Again the heterologous SLEV:WNV challenge elicited the highest PRNT titer peaking at 1:3,041 at week 2 post challenge, similar to SLEV PRNT results (Fig. 3B) . Similar to the EIA results, the homologous WNV:WNV challenge produced the next highest titers.
The immunologic responses of individual birds varied markedly within treatment groups, even though all birds were infected initially as indicated by positive viremia and/or EIA test results (Table 2) . PRNT end point titrations on week 6 (A6) after initial infection with SLEV gave variable results; for example, 5 birds had SLEV antibody titers < 4× WNV titers. The reciprocal was less variable, with only bird 2480 having equivocal titers. After homologous challenge, all birds except 2627 exhibited titers > 4× the competing virus. Differences between end point titers were markedly greater for the WNV:WNV than the SLEV:SLEV group. Heterologous challenge produced different results depending on the order of virus infection. On week C2 after heterologous challenge in the SLEV:WNV group, birds 2652 and 2656 had titers for SLEV > 4× WNV, birds 2649, 2651, and 2656 had titers for WNV > 4× SLEV, and birds 2650, 2653, and 2654 had titers for WNV ‫ס‬ SLEV. By week C6 titers in all birds, except 2653, decreased markedly, and all birds except 2652 and 2655 had WNV titers > SLEV titers. When the order of infection was reversed, all birds except 2484 on week C2 had WNV titers > SLEV. (Table 3 ). In the Coachella Valley where both SLEV and WNV were active during the previous summer, we could only identify 69% of EIA positive sera as either WNV or SLEV; significantly less (⌾ 2 ‫ס‬ 60.2, df ‫ס‬ 1, P < 0.001) than the 91% confirmed from Los Angeles where only WNV was active during both years. In Coachella Valley a significantly larger percentage of the EIA positive sera (⌾ 2 ‫ס‬ 66.7, df ‫ס‬ 2, P < 0.001) were negative by PRNT 80 [13%] or the results were equivocal with low titered end points [18%] than observed in Los Angeles. These latter results most likely were due to old infections, because our studies have shown that PRNT titers decay faster than EIA P/N ratios. Previous infection with either SLEV or WNV protected House finches from mortality during subsequent challenge, similar to results observed recently using a hamster laboratory model. 15 Sterilizing immunity during homologous and heterologous challenge with SLEV prevented detection of a viremia (i.e., viremia remained < 1.7 log 10 PFU/mL, our threshold of detection using Vero cell plaque assay). In contrast, heterologous challenge with WNV in birds previously infected with SLEV resulted in peak viremias that ranged from 2.7-6.4 log 10 PFU/mL. Viremias > 5 log 10 PFU/mL were considered sufficiently elevated to infect susceptible populations of California Culex mosquitoes. 8, 32 Interestingly, infection with SLEV following recovery from WNV infection elicited a consistent and significant rise in WNV PRNT, but not SLEV PRNT titers, perhaps because protective immunity prevented the immunologic response associated with a second viremia episode. This pattern is consistent with the concept of "original antigenic sin" previously recognized in mammalian hosts with sequential Flavivirus infections. 33 In contrast, infection with WNV following recovery from SLEV produced a very high antibody titers and a non-specific response that was highly variable among individual birds within this treatment group. Differences here were attributed to differential virulence associated with SLEV and WNV infection.
Our serology data pointed out problems in monitoring freeranging bird seroprevalence when SLEV and WNV are transmitted concurrently and sympatrically. Our field studies screen bird sera using an EIA and confirm possible positives with a P/N ratio > 2 using a PRNT against WNV or SLEV. For confirmation, the PRNT titer against the target virus must be Ն 4× the titer against the competing virus. In the current experiment 6 weeks after initial infection we would only have been able to confirm 8 of 14 birds infected with SLEV; 6 birds had PRNT 80 titers for SLEV < 4× for WNV. More WNV infections produced a specific antibody response and 11 of 12 birds had PRNT 80 titers against WNV > 4× against SLEV. Determination of the original or second infecting virus was virtually impossible after heterologous challenge, because some birds boosted antibody levels against the original virus, some produced equivocal cross-reacting antibody, and others produced antibody titers highest against the second infecting virus. Even reinfection with SLEV produced cross-reacting antibodies by week 6 post challenge that gave equivocal end point titers for WNV and SLEV. The impact of multiple sympatric Flavivirus transmission on avian diagnostics was demonstrated by comparing serological test results on birds collected in Coachella Valley where both WNV was active in 2003 and SLEV active since 2000 to Los Angeles where only WNV was active during 2003. We were able to confirm and identify only 69% of the EIA-positive sera from Coachella Valley, but 91% of sera from Los Angeles. We were able to confirm 87% of the EIA positives from Coachella Valley, but the infecting virus could not be ascertained in 18% of confirmed positives.
Although not well studied in birds, incomplete cross protection with members of the Japanese encephalitis serogroup has been observed in humans 34 and other mammals 15, 35, 36 leading to the notion that 2 members of this serogroup cannot coexist. 1 Australia seems to be a notable exception with both Kunjin and Murray Valley encephalitis endemic and transmitted principally by the same vector mosquito. 37, 38 The ongoing WNV epidemic in California has been associated with Data shown are the inverse of the PRNT80 end point titers using either WNV or SLEV on wk 6 after initial infection (A6) and at wks 2 (C2) and 6 (C6) after heterologous or homologous challenge. 
